AccumTM variants successfully increase breast cancer treatment potency
Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
Defence Therapeutics prepares to test its DC cancer vaccine against melanoma
Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...
Vaccine cold chain pioneers inaugurate new factory extension
Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters.
The factory extension...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
Defence Therapeutics’ new COVID vaccine achieves successful testing
Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model.
The new COVID vaccine – called...
Defence Therapeutics unveil novel HPV vaccine development programme
Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
Defence Therapeutics selects new variants to optimise drug delivery
Following a thorough evaluation process, Defence Therapeutics has selected the eight most successful variants of its Accum™ drug delivery technology.
Biotechnology company Defence Therapeutics continually works...
Organ support therapy ADVOS can effectively treat COVID-19 patients
A new study has demonstrated the efficacy of ADVOS organ support therapy in successfully treating COVID-19 patients.
ADVOS, the new blood purification procedure from ADVITOS,...
Defence Therapeutics: At the forefront of biotech innovation
In this article, we examine the future landscape of the Biotech sector, looking at the companies Defence Therapeutics, MorphoSys, BioNTech, and Pfizer.
Infectious diseases are...
Defence Therapeutics partners with pharmaceutical experts
Biotechnology company Defence Therapeutics has partnered with a pharmaceutical consultancy to maximise the potential of its developments.
In a bid to strengthen its development of...
B Medical Systems receives environmental backing for refrigeration products
Vaccine cold chain and medical refrigeration specialist B Medical Systems has received Energy Star certification for a range of its products.
B Medical Systems’ 115V...
New drug offers hope for MS sufferers on World Brain Day
As medical experts urgently call for action to tackle MS, one company has developed a drug it believes can treat the condition by repairing...
XPhyto expands infection prevention offering with new acquisition
Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions.
The move is the latest development in XPhyto’s...
B Medical Systems provides cold chain storage for Sputnik V vaccine rollout
Vaccine cold chain expert B Medical Systems has partnered with Dr. Reddy’s in the pan India rollout of the Sputnik V vaccines.
As part of...
XPhyto therapeutics supplies Berlin test centres with PCR tests
XPhyto Therapeutics Corp. has signed a master supply agreement with Beovita GmbH & Co. KG and Tackleberries GmbH for PCR Tests.
Beovita GmbH & Co....
Collaboration formed to test efficacy of breast cancer therapy
Defence Therapeutics Inc. has announced the establishment of a collaboration with the Curie Institute to evaluate the therapeutic efficacy of Accum-T-DM1 ADC in patient-derived...
Defence Therapeutics Accutox exhibits potent anti-cancer properties
Defence Therapeutics Inc. has announced a major breakthrough advance in its pre-clinical research program on its AccuTOX molecules as potent anti-cancer agents.
The AccumTM technology...
LeafCann CEO elected to CIC Board and Chair of Standards Group
Elisabetta Faenza has been elected to the UK-based Cannabis Industry Council (CIC) Board and has been selected to Chair its Standards Group.
The CIC consists...
Collecting saliva in a tube to test for COVID-19
The Norwegian municipality of Trondheim will be the first in the country to test for coronavirus by collecting saliva in a tube.
Trondheim in Norway...
Defence Therapeutics technology holds promise for future cancer therapy
Canadian biotechnology company Defence Therapeutics has developed a new generation platform technology that offers hope for future cancer therapy.
Defence Therapeutics’ ACCUM™ technology can be...
